The Future of Omega: 90% Oil to Powder with Superior Bioavailability
The Future of Omega: 90% Oil to Powder with Superior Bioavailability
Introducing a Game-Changing Innovation for the Nutraceutical Industry
At Puredia, we are committed to advancing health and wellness through science-backed innovation. We’re excited to announce the launch of our latest research on CrystDry™ Technology, published in Food Bioscience. This revolutionary process transforms Omega-rich oils into free fatty acid (FFA) powders, delivering exceptional bioavailability, purity, and efficiency—setting a new benchmark for the nutraceutical industry.
The Innovation of CrystDry™ Technology
Our proprietary CrystDry™ Technology offers a breakthrough in Omega oil processing by converting over 90% of Omega-rich oil into powder form. Using algae oil as an example, CrystDry™ can turn more than 90% of algae oil into powder, achieving an unprecedented 30% DHA content. In stark contrast to traditional microencapsulated powders, which have low conversion rates (10–20% DHA) and rely heavily on additives like maltodextrin, starch, carbohydrates, or proteins, CrystDry™ eliminates the need for these excipients—delivering a cleaner, more potent product.
Moreover, CrystDry™ innovatively delivers DHA in a free fatty acid (FFA) form, which requires no enzymatic hydrolysis for absorption, ensuring 76% higher bioavailability. This optimized delivery system allows DHA to be absorbed directly through cell membranes, dramatically improving efficiency and effectiveness. By combining unparalleled DHA purity, superior absorption, and additive-free formulation, CrystDry™ offers manufacturers a competitive edge in creating next-generation Omega-rich products.
Key Findings from Our Latest Research
Our study, published in Food Bioscience, demonstrates the superior performance of DHA-calcium fatty acid complexes (DHA-Ca, aka Algia™ 30% DHA Powder) processed using CrystDry™ Technology.
Here are the highlights:
Enhanced Bioavailability: DHA-Ca achieved 1.81 times higher peak plasma concentration (Cmax) and a 2.26-fold increase in total systemic exposure (AUC0–∞) compared to conventional algal oil DHA.
Faster Absorption: DHA-Ca reached peak concentration in just 6 hours versus 8 hours for traditional DHA.
Prolonged Retention: The mean residence time (MRT) of DHA-Ca extended to 29.71 hours, ensuring sustained DHA availability.
Targeted Tissue Delivery: DHA-Ca significantly increased DHA accumulation in critical organs, including the liver (2.28x), heart (2x), and brain (1.54x).
Metabolic Modulation: DHA-Ca activates pathways such as bile acid metabolism, fatty acid β-oxidation, and ABC transporter activity, ensuring superior bioavailability and systemic distribution.
These findings highlight DHA-Ca as the gold standard for delivering DHA with unparalleled efficiency and effectiveness, making it ideal for premium nutraceutical applications.
Introducing Our CrystDry™ FFA Product Portfolio
Designed to meet the growing demand for innovative Omega-rich supplements, our CrystDry™-produced FFA product line combines cutting-edge science with consumer-driven functionality:
1. Algia™ 30% DHA Powder
Purpose: Supports cardiovascular, cognitive, and visual health.
Dosage: Just 0.76g per day meets the EFSA-recommended RDI of 250mg DHA, contributing to the maintenance of normal heart function, brain health, and vision.
2. Omegia™FFA: Women’s Health & Beauty-From-Within
A tailored Omega 3,6,7,9 solution designed to meet the unique needs of women.
Key Benefits Include:
33% improved hydration and reduced vaginal dryness.
50% increase in vaginal lining integrity, enhancing comfort.
49% enhanced skin hydration for a youthful glow.
Relief from dry eyes and mouth.
Alleviation of 13 menopausal symptoms, promoting overall wellness.
3. CardiOmegia™FFA: Omega 7 for Cardiovascular Excellence and Metabolic Syndrome
A high-concentration Omega 7 formulation delivering standout cardiovascular and anti-inflammatory benefits.
Key Features Include:
Superior anti-inflammatory properties compared to Omega 3 DHA.
Synergistic effects when paired with DHA, amplifying cardiovascular health benefits.
Partner with Us to Elevate Your Product Line
Puredia’s CrystDry™-produced FFA products are the ultimate solution for brands seeking to deliver premium Omega-based supplements that meet consumer demands for efficacy, purity, and innovation.
Contact us today to discuss how CrystDry™ Technology can revolutionize your formulations and position your brand at the forefront of the nutraceutical market.
Let’s innovate the future of Omega nutrition together!
Warm regards,
The Puredia Team
Featured Ingredients
Clinically-proven menopause formula
Omega 3 ≥ 13%
Omega 6 ≥ 10%
Omega 7 ≥ 30%
Omega 9 ≥ 18%
Beta-carotene ≥ 100 mg/100g
Vitamin E ≥ 450 mg/100g
Available in oil and cold-water-soluble powder
TRI-CAP™ Microencapsulated
Sustainably & Responsibly Made
CardiOmegia™, Highest Omega 7 in Natural Triglyeride Form
100% Plant-Based
Organic-Certified
No Additive
Available in oil & powder form
TRI-CAP™ Microencapsulated
Sustainably & Responsibly Made
This ingredient is certified with:
Reference
Guo, J. et al. (2025)’, Food Bioscience, 69, p. 107002.